We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
New data from Moderna’s phase 3 COVID-19 vaccine trial have shown that the U.S. drugmaker’s two-dose inoculation remains highly effective against the virus six months after the second shot, including for severe infection, the company said Tuesday. Read More
Watchdog group Public Citizen has asked FDA to add recently banned weight loss drugs and antibiotics to the official list of drug products that were withdrawn or removed from the market for reasons of safety or effectiveness. Read More
A federal agency has drafted recommendations calling on Congress to require drugmakers to pay higher Medicaid rebates for high-cost specialty drugs until they complete confirmatory trials following accelerated approvals by the FDA. Read More
As Democratic lawmakers push ahead for legislation this congressional session aimed at lowering U.S. drug prices, PhRMA has come out with a seven-figure national ad campaign and a new policy agenda that puts forward ideas of its own for lowering the costs of drugs. Read More
An expert panel of the Centers for Disease Control and Prevention (CDC) is meeting today to review blood-clot incidents reported in a handful of patients who received Johnson & Johnson’s (J&J) one-dose COVID-19 vaccine. Read More
Sanofi has announced that it will invest $476 million in a multi-vaccine manufacturing facility in Singapore to mass produce vaccines for the Asian market. Read More
Eli Lilly has revised its supply deal with the U.S. government to focus on distributing the company’s COVID-19 antibody bamlanivimab along with another antibody, etesevimab — a combination that has proven to be effective against variant strains of the Sars-CoV-2 virus which causes COVID-19 infections. Read More
More harmful side effects were found in clinical study reports submitted to regulators than in listings about the same medicines in trial registries or published studies. Read More